Floatz logo

Bxcl501

Anesthesia, Local

King Saud UniversityPhase 3Active
B
60/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
45/ 100
Competitive Position
95/ 100

Competitive context

5 Active assets in the Anesthesia, Local cohort.

Asset / SponsorPhaseRating
(±)-1-BUTYL-2',6'-PIPECOLOXYLIDIDE MONOHYDROCHLORIDE
King Saud University
Phase 4BBB
RAMIFENTANYL
Medical University of Lublin
Phase 4BBB
CISATRACURIUM ION
Medical University of Lublin
Phase 4BBB
SUFENTANIL CITRATE
Medical University of Lublin
Phase 4BBB
Desflurane
Medical University of Lublin
Phase 4BBB

View all 20 →

Same molecule, other indications

Bxcl501 is also rated in:

Pain, ChronicDormant
A
Indicative ·
80 / 100
View asset →
Agitation,PsychomotorDormant
A
Indicative ·
80 / 100
View asset →
schizophreniform disorderDormant
A
Indicative ·
80 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →